Northwest Georgia Oncology Centers (NGOC)

Doctors:

Steven McCune

Walid Shaib

Clinical Trials in Georgia

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Cancer Type: Breast Cancer, Unknown Primary
Study Coordinator: Kristine Parker - 470-267-1480

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Cancer Type: Lung Cancer
Study Coordinator: Kristine Parker - 470-267-1480

A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
Cancer Type: Leukemia
Study Coordinator: Kristine Parker - 470-267-1480

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Cancer Type: Breast Cancer, Unknown Primary
Study Coordinator: Kristine Parker - 470-267-1480

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Cancer Type: Lung Cancer, Unknown Primary
Study Coordinator: Kristine Parker - 470-267-1480

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63)
Cancer Type: Breast Cancer
Study Coordinator: Kristine Parker - 470-267-1480